Antibody Targeting of B7-H4 Enhances the Immune Response in Urothelial Carcinoma
J. R. Podojil, A. P. Glaser, D. Baker, E. T. Courtois, D. Fantini, Y. Yu, V. Eaton, S. Sivajothi, P. Robson, S. Miller, J. J. Meeks
This study identifies B7-H4 as a potential therapeutic target in bladder cancer, showing that anti-B7-H4 antibodies enhance immune responses and reduce tumor size in preclinical models.
bioRxiv · Aug 10, 2019Cancer Biology